Pair Name | Platycodin D, Cetuximab | ||
Phytochemical Name | Platycodin D (PubChem CID: 162859 ) | ||
Anticancer drug Name | Cetuximab (PubChem CID: / ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Platycodin D, Cetuximab | |||
Disease Info | [ICD-11: 2B91] | Colorectal cancer | Investigative | |
Biological Phenomena | Inhibition-->Cell metastasis | |||
Gene Regulation | Down-regulation | Expression | CCND1 | hsa595 |
Down-regulation | Expression | CTNNB1 | hsa1499 | |
Down-regulation | Expression | MMP7 | hsa4316 | |
Down-regulation | Expression | MYC | hsa4609 | |
In Vitro Model | HT-29 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0320 |
Caco-2 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0025 | |
In Vivo Model | HT29 and CaCo2 cells were trypsinized and injected into the tail vein of nu/nu nude mice with a concentration of 2×10⁵/0.2 ml to establish a model for metastatic lung tumors. | |||
Result | Our findings provide a potential strategy to inhibit CRC metastasis during cetuximab therapy by addition of platycodin D. |
No. | Title | Href |
---|---|---|
1 | Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells. Clin Exp Metastasis. 2023 Aug;40(4):339-356. doi: 10.1007/s10585-023-10218-6. | Click |